Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

RNW vs LFST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

RNW Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

RNW Overall Winner 6-Pillar Tally: RNW 5 – 1 LFST Matrix Metrics: RNW 8 – 2 LFST

As of Nov 20, 2026, ReNew Energy Global plc Class A (RNW) is the stronger overall head-to-head candidate over LifeStance Health Group, Inc. (LFST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RNW carries a Unified Composite Score of 55.6/100 (HOLD) at $6.88 (30.3x Forward P/E, 46.7% operating margin), whereas LFST carries 36.9/100 (SELL) at $13.82 (30.8x Forward P/E, 6.4% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RNW vs LFST
RNW NASDAQ Head-to-Head Winner
ReNew Energy Global plc Class A Ordinary Shares
Electric Services
$6.88
-0.58% 1D
Market Cap $2.5B
TTM Revenue $1.65B
Forward P/E 30.3x
Beta / 30D Vol 0.60β · 4% Vol
Unified Composite Score
55.6 / 100 HOLD
Tech 43.0 Fund 52.0 Flow 54.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.3 · SMA20: $6.92 · SMA50: $6.88
LFST NASDAQ
LifeStance Health Group, Inc. Common Stock
Services-Health Services
$13.82
+3.6% 1D
Market Cap $5.1B
TTM Revenue $1.68B
Forward P/E 30.8x
Beta / 30D Vol 0.68β · 45% Vol
Unified Composite Score
36.9 / 100 SELL
Tech 38.0 Fund 35.0 Flow 50.0 Mom 11.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 54
RSI-14: 53.6 · SMA20: $13.80 · SMA50: $12.90

6-Pillar Scorecard Institutional Category Breakdown (RNW 5 – 1 LFST)

Columns: Metric · RNW · LFST
1. Valuation Multiples RNW
Forward P/E 30.3x 30.8x
Trailing P/E 18.2x 74.1x
PEG Ratio N/M N/M
EV / Revenue 6.9x 3.0x
2. Growth & Scale RNW
Revenue Growth (YoY) +28.2% +25.3%
Earnings Growth (YoY) +42.5% N/A
TTM Revenue (USD) $1.65B $1.68B
Market Cap $2.5B $5.1B
3. Profitability & Quality RNW
Gross Margin 82.1% 34.4%
Operating Margin 46.7% 6.4%
Net Profit Margin 8.4% 4.3%
Return on Equity (ROE) 8.6% 4.8%
4. Balance Sheet & Cash Flow LFST
Cash Generation (TTM) -$42M $164M EBITDA
Cash Flow Margin -2.6% 9.8% EBITDA Mgn
Net Cash / Leverage $8.89B Net Debt (5.82x D/E) $3.92 Book/Sh · 4.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning RNW
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 0.3% (<1st %ile) 42.6% (50th %ile)
Put/Call OI Skew 0.02x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat RNW
OpEx & R&D Intensity 35.4% of Rev ($585M) 28.0% of Rev ($470M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Utilities - Renewable Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RNW (8) vs LFST (2)
Institutional Metric RNW LFST Criterion Row Edge
Market Capitalization
Scale
$2.5B $5.1B Larger Scale LFST
Trailing P/E Ratio
Valuation
18.2x 74.1x Lower Multiple RNW
Forward P/E Ratio
Valuation
30.3x 30.8x Lower Multiple RNW
Revenue Growth (YoY)
Growth
+28.2% +25.3% Higher Growth RNW
Operating Margin (TTM)
Profitability
46.7% 6.4% Higher Margin RNW
Net Profit Margin
Profitability
8.4% 4.3% Higher Margin RNW
Return on Equity (ROE)
Capital Efficiency
8.6% 4.8% Higher ROE RNW
52-Week Range Position
Momentum
76% ($4–$8) 81% ($6–$16) Stronger Trend LFST
Beta / 30D Volatility
Risk Regime
0.60β · 4% Vol 0.68β · 45% Vol Lower Realized Risk RNW
Unified Institutional Score
Composite Signal
55.6 / 100 (HOLD) 36.9 / 100 (SELL) Higher Composite RNW
Trailing 12M Revenue (USD)
Operating Scale
$1.65B $1.68B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
82.1% 34.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 6.9x EV/Rev N/M PEG · 3.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$42M ($8.89B Net Debt (5.82x D/E)) $164M EBITDA ($3.92 Book/Sh · 4.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon LFST +10.03 pp
RNW: +0.0% · LFST: +10.03%
3M Horizon LFST +12.47 pp
RNW: +1.18% · LFST: +13.65%
6M Horizon LFST +70.79 pp
RNW: +16.22% · LFST: +87.01%
1Y Horizon LFST +132.13 pp
RNW: -8.51% · LFST: +123.62%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RNW vs LFST. Trailing 12-month operating profitability (RNW 46.7% vs LFST 6.4%) and valuation multiples (RNW 30.3x vs LFST 30.8x Forward P/E) are benchmarked directly in Pillar 4 below.

RNW ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.65B
Gross Margin82.1%
Op. Margin46.7%
ROE / Fwd P/E8.6% · 30.3x
LFST ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.68B
Gross Margin34.4%
Op. Margin6.4%
ROE / Fwd P/E4.8% · 30.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RNW CONSOLIDATION
121d in phase · OBV NEUTRAL
Current IV 0.3%
IV Percentile <1st %ile
Put/Call OI Skew 0.02x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RNW Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LFST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 42.6%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LFST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RNW Moat Profile High-Margin Pricing Power Moat
Utilities - Renewable Operator
Competes within the Utilities - Renewable value chain with $2.5B market capitalization and 46.7% operating margin.
OpEx & R&D Reinvestment 35.4% of Rev ($585M)
90D Engineering Disclosures 0 Published
LFST Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.1B market capitalization and 6.4% operating margin.
OpEx & R&D Reinvestment 28.0% of Rev ($470M)
90D Engineering Disclosures 0 Published

Investor FAQ RNW vs LFST Key Questions & Quantitative Answers

As of Nov 20, 2026, ReNew Energy Global plc Class A (RNW) is the stronger overall head-to-head candidate over LifeStance Health Group, Inc. (LFST) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RNW carries a Unified Composite Score of 55.6/100 (HOLD) at $6.88 (30.3x Forward P/E, 46.7% operating margin), whereas LFST carries 36.9/100 (SELL) at $13.82 (30.8x Forward P/E, 6.4% operating margin). Technically, RNW sits in a Neutral phase (RSI 41.3, CONSOLIDATION options structure) and LFST sits in a Markup phase (RSI 53.6, UNCLASSIFIED options structure).

RNW leads the Growth & Scale pillar: RNW posts +28.2% YoY revenue growth and +42.5% YoY earnings growth on $1.65B TTM revenue (82.1% gross margin, 46.7% operating margin), compared with LFST at +25.3% YoY revenue growth and N/A YoY earnings growth on $1.68B TTM revenue (34.4% gross margin, 6.4% operating margin). On trailing 12-month operating scale, RNW generates $1.65B in USD-normalized revenue versus $1.68B for LFST. In operating R&D and SG&A reinvestment, RNW deploys 35.4% of Rev ($585M) (0 90-day corporate R&D disclosures) versus 28.0% of Rev ($470M) (0 disclosures) for LFST.

RNW screens cheaper on headline valuation multiples. RNW trades at 30.3x Forward P/E, 18.2x Trailing P/E, N/M PEG, and 6.9x EV/Revenue (-2.6% FCF margin), whereas LFST trades at 30.8x Forward P/E, 74.1x Trailing P/E, N/M PEG, and 3.0x EV/Revenue (9.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RNW (8.6% ROE) versus LFST (4.8% ROE) capital efficiency.

In options market volatility and institutional positioning, RNW carries 0.3% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.02x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.60β · 4% Vol realized risk). By comparison, LFST carries 42.6% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.68β · 45% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.